Vivani treats first patient with long-lasting drug implant for weight loss – Medical Device Network

Vivani treats first patient with long-lasting drug implant for weight loss  Medical Device Network

New ‘natural’ GLP-1 booster that can be added to any food for weight loss to hit shelves within the next year – New York Post

New ‘natural’ GLP-1 booster that can be added to any food for weight loss to hit…

Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today – Quartz

Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today  Quartz

Vivani treats first patient with long-lasting drug implant for weight loss

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani…

Eating in This Order Could Have Similar Benefits to Ozempic – Parade Magazine

Eating in This Order Could Have Similar Benefits to Ozempic  Parade Magazine

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults – BioSpace

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant…

Could popular weight-loss drugs help treat addiction and dementia? – AAMC

Could popular weight-loss drugs help treat addiction and dementia?  AAMC

Could popular weight-loss drugs help treat addiction and dementia? – AAMC

Could popular weight-loss drugs help treat addiction and dementia?  AAMC

Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial – Pharmacy Times

Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial  Pharmacy Times

Emergent signs financial investment agreement with Swiss Rockets

Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech…